持续性房颤患者首次射频消融术后复发风险相关因素分析
Analysis of Relevant Risk Factors for Recurrence after First Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation
DOI: 10.12677/ACM.2020.1012463, PDF,   
作者: 韩伟东, 赵 青, 张 鹏:青岛大学附属医院心血管内科,山东 青岛;郭艳杰:潍坊市人民医院心脏超声科,山东 潍坊;窦菁菁:青岛大学附属心血管病医院心脏超声科,山东 青岛;孙 品*:青岛大学附属医院心脏超声科,山东 青岛
关键词: 房颤射频消融术复发病程左心房内径P波离散度Atrial Fibrillation Radiofrequency Ablation Recurrence Course Left Atrium Diameter P-Wave Dispersion
摘要: 目的:分析持续性心房颤动(Persistent atrial fibrillation, PAF)患者首次射频消融术后房颤复发的影响因素,为临床提供参考依据。方法:选取60名于2018-07至2019-07于青岛大学附属医院住院行射频消融术的PAF患者。根据患者1年内是否复发分为复发组(n = 30)、非复发组(n = 30)。比较两组患者临床资料,分析持续房颤患者射频消融术后复发的影响因素,采用logistic回归分析确定PAF患者射频术后复发的独立危险因素。结果:复发组的病程、术前左心房内径(left atrial diameter, LAD)、N端脑钠肽前体(N-terminal pro-brain natriuretic peptide, NT-proBNP)、白蛋白、术后P波离散度、早期复发均显著高于未复发组,复发组的高密度脂蛋白显著低于未复发组,差异有统计学意义(P < 0.05)。logistic回归分析显示,病程、术前LAD、术后P波离散度共三个指标是影响PAF患者射频消融术后复发的独立危险因素(OR > 1)。结论:病程、术前左心房内径、术后P波离散度可在一定程度上评估PAF患者射频消融术后复发风险。
Abstract: Objective: To analyse Persistent atrial fibrillation (PAF) in patients with the influence factors of atrial fibrillation recurrence after radiofrequency ablation for the first time. Methods: 60 PAF patients who underwent radiofrequency ablation in The Affiliated Hospital of Qingdao University from 2018-07 to 2019-07 were selected. Patients were divided into recurrent group (n = 30) and non-recurrent group (n = 30) according to whether they had recurred within 1 year. The clinical data of the two groups were compared to analyze the factors influencing the recurrence of patients with continuous atrial fibrillation after radiofrequency ablation. Results: Recurrence group of course, left atrium diameter (LAD), N-terminal pro-brain natriuretic peptide (NT-proBNP), albumin, P-wave dispersion (PWD), early recurrence rate were significantly higher than non-recur- rence group, the difference was statistically significant (P < 0.05), recurrence group of high-density lipoprotein cholesterol (HDL-c) significantly below non-recurrence group, the difference was statistically significant (P < 0.05). Logistic regression analysis showed that there was a significant positive correlation between disease course, LAD and P-wave dispersion and recurrence (P < 0.05), and they were independent risk factors for recurrence (OR > 1). Conclusion: The course of disease, preoperative left atrial diameter, and postoperative P-wave dispersion can be used to evaluate the possibility of recurrence in patients with PAF after radiofrequency ablation.
文章引用:韩伟东, 赵青, 郭艳杰, 窦菁菁, 张鹏, 孙品. 持续性房颤患者首次射频消融术后复发风险相关因素分析[J]. 临床医学进展, 2020, 10(12): 3096-3102. https://doi.org/10.12677/ACM.2020.1012463

参考文献

[1] Zhou, Z. and Hu, D. (2008) An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China. Journal of Epidemiology, 18, 209-216. [Google Scholar] [CrossRef
[2] Chiang, C.E., Okumura, K., Zhang, S., et al. (2017) 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation. Journal of Arrhythmia, 33, 345-367. [Google Scholar] [CrossRef] [PubMed]
[3] Mansour, M., Heist, E.K., Agarwal, R., et al. (2018) Stroke and Cardiovascular Events after Ablation or Antiarrhythmic Drugs for Treatment of Patients with Atrial Fibrillation. American Journal of Cardiology, 121, 1192-1199. [Google Scholar] [CrossRef] [PubMed]
[4] Callans, D.J. (2008) Apples and Oranges Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation. Circulation, 118, 2488-2490. [Google Scholar] [CrossRef
[5] Jais, P., Cauchemez, B., Macle, L., et al. (2008) Catheter Ablation versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study. Circulation, 118, 2498-2505. [Google Scholar] [CrossRef
[6] Yi, F., Hou, W., Zhou, C., et al. (2019) Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy. Journal of Cardiovascular Pharmacology, 73, 241-247. [Google Scholar] [CrossRef
[7] Mujović, N., Marinković, M., Lenarczyk, R., et al. (2017) Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians. Advances in Therapy, 34, 1897-1917. [Google Scholar] [CrossRef] [PubMed]
[8] Raatikainen, M.J.P., Hakalahti, A., Uusimaa, P., et al. (2015) Radiofrequency Catheter Ablation Maintains Its Efficacy Better than Antiarrhythmic Medication in Patients with Paroxysmal Atrial Fibrillation: On-Treatment Analysis of the Randomized Controlled MANTRA-PAF Trial. International Journal of Cardiology, 198, 108-114. [Google Scholar] [CrossRef] [PubMed]
[9] Wilber, D.J., Pappone, C., Neuzil, P., et al. (2010) Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients with Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial. JAMA, 303, 333-340. [Google Scholar] [CrossRef] [PubMed]
[10] 黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗的建议-2018 [J]. 中国心脏起搏与心电生理杂志, 2018, 32(4): 6-59.
[11] Pathik, B., Kalman, J.M., Walters, T., et al. (2018) Transient Rotor Activity During Prolonged 3-Dimensional Phase Mapping in Human Persistent Atrial Fibrillation. JACC: Clinical Electrophysiology, 4, 72-83. [Google Scholar] [CrossRef] [PubMed]
[12] Swarup, V., Baykaner, T., Rostamian, A., et al. (2015) Stability of Rotors and Focal Sources for Human Atrial Fibrillation: Focal Impulse and Rotor Mapping (FIRM) of AF Sources and Fibrillatory Conduction. Journal of Cardiovascular Electrophysiology, 25, 1284-1292. [Google Scholar] [CrossRef] [PubMed]
[13] Van der Does, L.J., Kik, C., Bogers, A.J., Allessie, M.A. and de Groot, N.M.S. (2015) Dynamics of Endo- and Epicardial Focal Fibrillation Waves at the Right Atrium in a Patient with Advanced Atrial Remodelling. Canadian Journal of Cardiology, 32, 1260.e19-1260.e21. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, J., Huang, C.X., Bao, M.W., et al. (2005) Ectopic Activity Induced by Elevated Atrial Pressure in Rabbit Pulmonary Vein in Vitro. CHINESE MED J-PEKING, 118, 1210-1213.
[15] 江洪, 黄从新, 唐其柱, 等. 肺静脉异常电活动引起持续性心房颤动的电生理特点和消融治疗[J]. 中华心血管病杂志, 2004, 32(3): 211-216.
[16] Nedios, S., Koutalas, E., Kosiuk, J., et al. (2013) Comparison of Left Atrial Diameters in Computed Tomography and Echocardiography as Predictors of Long-Term Success after Catheter Ablation of Atrial Fibrillation. European Heart Journal, 34, 2340. [Google Scholar] [CrossRef
[17] Orczykowski, M., Urbanek, P., Bodalski, R., et al. (2017) Risk Factors of Atrial Fibrillation Recurrence Despite Successful Radiofrequency Ablation of Accessory Pathway: At 11 Years of Follow-Up. Cardiology Journal, 24, 597-603. [Google Scholar] [CrossRef
[18] Arora, R. and Koduri, H.K. (2014) Mechanisms of Atrial Fibrillation. In: Kibos, A., Knight, B., Essebag, V., Fishberger, S., Slevin, M. and Țintoiu, I., Eds., Cardiac Arrhythmias, Springer, London, 401-412. [Google Scholar] [CrossRef
[19] 易茜, 马瑞彦. 心房结构重构在心房颤动的发生及维持中的作用[J]. 中国循环杂志, 2015, 30(8): 813-816.
[20] Matsuo, S., Lim, K.-T. and Haissaguerre, M. (2007) Ablation of Chronic Atrial Fibrillation. Heart Rhythm, 4, 1461-1463. [Google Scholar] [CrossRef] [PubMed]
[21] Jadidi, A., Weber, R., Neumann, F.-J., et al. (2018) The Duration of the Amplified Sinus-P-Wave Identifies Presence of Left Atrial Low Voltage Substrate and Predicts Outcome after Pulmonary Vein Isolation in Patients with Persistent Atrial Fibrillation. JACC, 4, 531-543. [Google Scholar] [CrossRef] [PubMed]